Neuro42 Company

Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.

Total Funding: 7800000.0
Headquarters: Oakland, California, United States
Funding Status: Early Stage Venture
Last Funding Type: Series A
Last Funding Date: 2021-07-27
Investors Number: 4.0
Founded Date: 2020-01-01
Industry: Neurodegenerative disease diagnosis and treatment